limestone has been researched along with Apoplexy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aragaki, AK; Cauley, J; Howard, B; Jiang, X; Johnson, KC; Kelsey, AM; LeBlanc, ES; Manson, JE; Martin, LW; Nudy, M; OʼSullivan, DM; Payne, ME; Robbins, JA; Schnatz, PF; Shikany, JM; Stefanick, ML | 1 |
| Bigazzi, R; Casani, A; Di Giorgio, A; Grazi, G; Manca Rizza, G; Migliori, M; Panichi, V; Paoletti, S; Rosati, A; Ruggeri, M; Scatena, A; Sgambato, A | 1 |
1 trial(s) available for limestone and Apoplexy
| Article | Year |
|---|---|
Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease.
Topics: Aged; Calcium; Calcium Carbonate; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Postmenopause; Prospective Studies; Risk Factors; Stroke; United States; Women's Health | 2019 |
1 other study(ies) available for limestone and Apoplexy
| Article | Year |
|---|---|
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study.
Topics: Acetates; Aged; C-Reactive Protein; Calcium Carbonate; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Cost-Benefit Analysis; Databases, Factual; Female; Humans; Kidney Failure, Chronic; Male; Markov Chains; Middle Aged; Phosphates; Prospective Studies; Quality-Adjusted Life Years; Renal Dialysis; Sevelamer; Stroke; Survival Analysis; Vitamin D | 2015 |